While much historical work on NF-κB suggested a primarily pro-tumor function of NF-κB activation in PDAC tied tightly to KRAS, more recent studies revealed simultaneous antitumor effects mediated by a complex signaling network affecting immune cells in the TME [10]. This evidence concerns the gene NFKB1 and neoplasm.